These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 19754789)

  • 1. A novel small molecule Met inhibitor, PF2362376, exhibits biological activity against osteosarcoma.
    Liao AT; McCleese J; Kamerling S; Christensen J; London CA
    Vet Comp Oncol; 2007 Sep; 5(3):177-96. PubMed ID: 19754789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. met oncogene activation qualifies spontaneous canine osteosarcoma as a suitable pre-clinical model of human osteosarcoma.
    De Maria R; Miretti S; Iussich S; Olivero M; Morello E; Bertotti A; Christensen JG; Biolatti B; Levine RA; Buracco P; Di Renzo MF
    J Pathol; 2009 Jul; 218(3):399-408. PubMed ID: 19402129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization, expression and function of c-Met in canine spontaneous cancers.
    Liao AT; McMahon M; London C
    Vet Comp Oncol; 2005 Jun; 3(2):61-72. PubMed ID: 19379214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomerase activity in canine osteosarcoma.
    Kow K; Bailey SM; Williams ES; Withrow S; Lana SE
    Vet Comp Oncol; 2006 Sep; 4(3):184-7. PubMed ID: 19754815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases.
    Qian F; Engst S; Yamaguchi K; Yu P; Won KA; Mock L; Lou T; Tan J; Li C; Tam D; Lougheed J; Yakes FM; Bentzien F; Xu W; Zaks T; Wooster R; Greshock J; Joly AH
    Cancer Res; 2009 Oct; 69(20):8009-16. PubMed ID: 19808973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a new canine osteosarcoma cell line.
    Séguin B; Zwerdling T; McCallan JL; DeCock HE; Dewe LL; Naydan DK; Young AE; Bannasch DL; Foreman O; Kent MS
    Vet Comp Oncol; 2006 Dec; 4(4):232-40. PubMed ID: 19754807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-throughput cell-based screening of 4910 known drugs and drug-like small molecules identifies disulfiram as an inhibitor of prostate cancer cell growth.
    Iljin K; Ketola K; Vainio P; Halonen P; Kohonen P; Fey V; Grafström RC; Perälä M; Kallioniemi O
    Clin Cancer Res; 2009 Oct; 15(19):6070-8. PubMed ID: 19789329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel role of interleukin-13 receptor alpha2 in pancreatic cancer invasion and metastasis.
    Fujisawa T; Joshi B; Nakajima A; Puri RK
    Cancer Res; 2009 Nov; 69(22):8678-85. PubMed ID: 19887609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic and Transcriptomic Characterization of Canine Osteosarcoma Cell Lines: A Valuable Resource in Translational Medicine.
    Gola C; Giannuzzi D; Rinaldi A; Iussich S; Modesto P; Morello E; Buracco P; Aresu L; De Maria R
    Front Vet Sci; 2021; 8():666838. PubMed ID: 34079834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SC68896, a novel small molecule proteasome inhibitor, exerts antiglioma activity in vitro and in vivo.
    Roth P; Kissel M; Herrmann C; Eisele G; Leban J; Weller M; Schmidt F
    Clin Cancer Res; 2009 Nov; 15(21):6609-18. PubMed ID: 19825946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corrigendum to "SOMCL-863, a novel, selective and orally bioavailable small-molecule c-Met inhibitor, exhibits antitumor activity both in vitro and in vivo" [Cancer Lett. 351 (2014) 143-50].
    Wang L; Ai J; Shen Y; Zhang H; Peng X; Huang M; Zhang A; Ding J; Geng M
    Cancer Lett; 2020 Aug; 486():71-72. PubMed ID: 32475789
    [No Abstract]   [Full Text] [Related]  

  • 12. Some Problems Met by a Practitioner.
    Gendreau LA
    Can J Comp Med Vet Sci; 1945 Aug; 9(8):205-9. PubMed ID: 17648143
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterizing the metabolic role of STAT3 in canine osteosarcoma.
    Gardner HL; Fenger JM; Roberts RD; London CA
    Vet Comp Oncol; 2022 Dec; 20(4):817-824. PubMed ID: 35608271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular targets for anticancer therapies in companion animals and humans: what can we learn from each other?
    Beltrán Hernández I; Kromhout JZ; Teske E; Hennink WE; van Nimwegen SA; Oliveira S
    Theranostics; 2021; 11(8):3882-3897. PubMed ID: 33664868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managing sarcoma: where have we come from and where are we going?
    Bleloch JS; Ballim RD; Kimani S; Parkes J; Panieri E; Willmer T; Prince S
    Ther Adv Med Oncol; 2017 Oct; 9(10):637-659. PubMed ID: 28974986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of novel polymorphisms in the ckit gene of canine patients with lymphoma, melanoma, haemangiosarcoma, and osteosarcoma.
    Gramer I; Kessler M; Geyer J
    Vet Res Commun; 2016 Jun; 40(2):89-95. PubMed ID: 26971271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Personalized comprehensive molecular profiling of high risk osteosarcoma: Implications and limitations for precision medicine.
    Subbiah V; Wagner MJ; McGuire MF; Sarwari NM; Devarajan E; Lewis VO; Westin S; Kato S; Brown RE; Anderson P
    Oncotarget; 2015 Dec; 6(38):40642-54. PubMed ID: 26510912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pro-tumorigenic effects of transforming growth factor beta 1 in canine osteosarcoma.
    Portela RF; Fadl-Alla BA; Pondenis HC; Byrum ML; Garrett LD; Wycislo KL; Borst LB; Fan TM
    J Vet Intern Med; 2014; 28(3):894-904. PubMed ID: 24684686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canine osteosarcoma cells exhibit resistance to aurora kinase inhibitors.
    Cannon CM; Pozniak J; Scott MC; Ito D; Gorden BH; Graef AJ; Modiano JF
    Vet Comp Oncol; 2015 Mar; 13(1):48-59. PubMed ID: 23410058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone sarcomas: from biology to targeted therapies.
    Gaspar N; Di Giannatale A; Geoerger B; Redini F; Corradini N; Enz-Werle N; Tirode F; Marec-Berard P; Gentet JC; Laurence V; Piperno-Neumann S; Oberlin O; Brugieres L
    Sarcoma; 2012; 2012():301975. PubMed ID: 23226965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.